v3.25.4
Fourth Quarter Financial Results (unaudited) (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2025
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Quarterly Financial Information Disclosure [Abstract]                              
Net revenues $ 16,618                       $ 61,160 $ 56,334 $ 54,318
Gross margin 12,066                            
Net earnings attributable to AbbVie Inc. $ 1,816                       $ 4,226 $ 4,278 $ 4,863
Basic earnings per share (in dollars per share) $ 1.02                       $ 2.37 $ 2.40 $ 2.73
Diluted earnings per share (in dollars per share) 1.02                       2.36 2.39 2.72
Cash dividends declared per common share (in dollars per share) $ 1.73 $ 1.64 $ 1.64 $ 1.64 $ 1.64 $ 1.55 $ 1.55 $ 1.55 $ 1.55 $ 1.48 $ 1.48 $ 1.48 $ 6.65 $ 6.29 $ 5.99